Home > Healthcare > Medical Devices > Therapeutic Devices > Gastrointestinal Stents Market

Gastrointestinal Stents Market Trends

  • Report ID: GMI3338
  • Published Date: Aug 2023
  • Report Format: PDF

Gastrointestinal Stents Market Trends

Increasing prevalence of gastrointestinal cancer is anticipated to drive the market expansion. Gastrointestinal cancers, including esophageal, gastric, and colorectal cancers, are among the most common types of cancer worldwide. For instance, according to the European Commission data in 2020, around 341,391 new cases of colorectal cancer were witnessed in the Europe. The growing incidence of these cancers contributes to a larger patient pool requiring interventions such as stent placement to address complications like obstructions and strictures. In advanced stages of gastrointestinal cancer, patients experience symptoms like difficulty swallowing, pain, and obstruction. Gastrointestinal stents are used as part of palliative care to provide relief, improve quality of life, and maintain proper digestive function, which in turn drives demand for these devices.
 

Advancements in screening techniques and increased awareness of early detection have led to more cases of gastrointestinal cancer being diagnosed at earlier stages. Gastrointestinal stent placement is often performed using minimally invasive techniques such as endoscopy. This approach appeals to both patients and healthcare providers as it reduces patient trauma, shortens hospital stays, and accelerates recovery compared to traditional surgical options. The increasing prevalence of gastrointestinal cancer creates a significant demand for interventions that can address associated complications. Gastrointestinal stents provide an effective and minimally invasive solution, making them a crucial component of cancer care.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Gastrointestinal stents industry value was USD 465.2 million in 2022 and will reach over USD 776.3 million by the end of 2032.

The hospitals segment held a major market share and accounted for around USD 224.1 million in 2022 as these healthcare settings are equipped with advanced diagnostic and interventional equipment, facilitating precise diagnosis, treatment planning, and stent placement procedures.

North America gastrointestinal stents market value was USD 169.9 million in 2022 and it is expected to witness substantial growth through 2032 due to factors like an increase in the number of patients suffering from gastrointestinal disorders and an expanding elderly population.

Becton Dickinson and Company, Boston Scientific Corporation, Cantel Medical, Conmed Corporation, Cook Medical, ELLA-CS, s.r.o., Gore Medical, Hobbs Medical, Inc., Medtronic plc, Micro-Tech (Nanjing) Co., Ltd., Olympus America among others.

Gastrointestinal Stents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 279
  • Countries covered: 20
  • Pages: 160
 Download Free Sample